Pacer Advisors’s Astrana Health ASTH Stock Holding History

Pacer Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-181,910	Closed	-$5.16M	–	3874
2025 Q3	$5.16M	Buy	+181,910	New	+$4.93M	0.01%	674

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Pacer Advisors's ASTH Position: Q4 2025 in Review

Pacer Advisors sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 181,910 shares — an estimated $5.16M sold.

Pacer Advisors first reported a position in ASTH in Q3 2025 and held it in 1 quarter. The position peaked at $5.16M in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

Pacer Advisors reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
Pacer Advisors sold 181,910 Astrana Health shares in Q4 2025, an estimated $5.16M.
Pacer Advisors first reported a position in Astrana Health in Q3 2025 and held it in 1 quarter.
Pacer Advisors's Astrana Health position peaked at $5.16M in Q3 2025.
175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Pacer Advisors's 13F filing for Q4 2025, filed 4 Feb 2026.